142 related articles for article (PubMed ID: 28963807)
1. Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Lechien JR; Nassri A; Kindt N; Brown DN; Journe F; Saussez S
Head Neck; 2017 Dec; 39(12):2573-2584. PubMed ID: 28963807
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Wang SS; Cen X; Liang XH; Tang YL
Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
[TBL] [Abstract][Full Text] [Related]
3. [MIF in head and neck cancer: a new therapeutic target ?].
Lechien JR; Kindt N; Costa Pde A; Chantrain G; Preillon J; Laurent G; Saussez S
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):67-74. PubMed ID: 24683815
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor involvement in breast cancer (Review).
Richard V; Kindt N; Saussez S
Int J Oncol; 2015 Nov; 47(5):1627-33. PubMed ID: 26412712
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Bilsborrow JB; Doherty E; Tilstam PV; Bucala R
Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
[No Abstract] [Full Text] [Related]
6. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Subbannayya T; Leal-Rojas P; Barbhuiya MA; Raja R; Renuse S; Sathe G; Pinto SM; Syed N; Nanjappa V; Patil AH; Garcia P; Sahasrabuddhe NA; Nair B; Guerrero-Preston R; Navani S; Tiwari PK; Santosh V; Sidransky D; Prasad TS; Gowda H; Roa JC; Pandey A; Chatterjee A
BMC Cancer; 2015 Nov; 15():843. PubMed ID: 26530123
[TBL] [Abstract][Full Text] [Related]
7. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
[TBL] [Abstract][Full Text] [Related]
11. Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
O'Reilly C; Doroudian M; Mawhinney L; Donnelly SC
Med Res Rev; 2016 May; 36(3):440-60. PubMed ID: 26777977
[TBL] [Abstract][Full Text] [Related]
12. Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Guo P; Wang J; Liu J; Xia M; Li W; He M
Tumour Biol; 2015 Jul; 36(7):5095-102. PubMed ID: 25716200
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
[TBL] [Abstract][Full Text] [Related]
14. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
15. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
[TBL] [Abstract][Full Text] [Related]
17. Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor.
Xia W; Xie C; Jiang M; Hou M
Mol Cell Biochem; 2015 Jun; 404(1-2):11-24. PubMed ID: 25701358
[TBL] [Abstract][Full Text] [Related]
18. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.
Kindt N; Journe F; Laurent G; Saussez S
Oncol Lett; 2016 Oct; 12(4):2247-2253. PubMed ID: 27698786
[TBL] [Abstract][Full Text] [Related]
19. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
20. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Wang Z; Xue Y; Wang P; Zhu J; Ma J
Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
